Systemic Adjuvant Treatment of T1a and T1b N0M0 HER2 + Breast Carcinomas; an AERIO/UNICANCER Study (Abstract P2-18-03; Peron J et al.) et HER2 expression is the major risk factor for recurrence in pT1a-b, N0 breast cancer: a French regional population-bas
- Xavier PIVOT (Besançon)
- 12/01/2012